Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Roche taps Simcere for trispecific T cell engager pact with $75M upfront

For the second time in as many weeks, Roche's business development team has lined up a deal with a Chinese biopharma. The Swiss drug giant this time is teaming with Simcere Zaiming on a preclinical ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Tuesday 1 September →